Showing results (11-20 of 79) with videos related to
Sort By:
Pageof 8
La Nouvelle Presse Medicale|May 26, 1979
[The treatment of advanced malignant melanoma with vaccina oncolysates (author's transl)]M K WallackSurgery|October 1, 1984
Serologic response to human melanoma lines from patients with melanoma undergoing treatment with vaccinia melanoma oncolysatesM K Wallack, M MichaelidesSurgery, Gynecology & Obstetrics|October 1, 1990
Management of the pregnant patient with carcinoma of the breastY Barnavon, M K WallackJournal of Surgical Oncology|January 1, 1981
Cancer to the inguinal nodes from an unknown primary siteM K Wallack, B ReynoldsCancer|March 15, 1981
Inflammatory oncotaxis after testing the skin of the cancer patientT Shine, M K WallackImmunology Letters|December 1, 1989
Functionally different HTLV I-infected T cell lines with the same phenotype derived from a patient with melanomaM Sivanandham, B MukherjiAmerican Journal of Clinical Oncology|October 1, 1984
Survival after malignant melanoma in a black child. A case report and review of the literatureM W Moritz, M K WallackJournal of the American College of Surgeons|April 1, 1997
The surgeon's database for AIDS: a collective reviewD R Flum, M K WallackCancer|January 1, 1995
A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanomaM K Wallack, M Sivanandham, C M Balch, et al.Pageof 8